Global Self-Monitoring Blood Glucose Strips Market Growth 2024-2030
The Self-Monitoring Blood Glucose Strips market, valued at US$ 23,230 million in 2024, is expected to grow as more people with diabetes embrace self-monitoring tools.
The global self-monitoring blood glucose (SMBG) strips market has witnessed significant growth due to the increasing prevalence of diabetes, rising health awareness, and advancements in healthcare technology. Diabetes has become a major global health concern, affecting millions of people across different age groups. The growing burden of diabetes is driving the demand for self-monitoring blood glucose devices, particularly test strips, which allow individuals to regularly check their blood sugar levels without visiting a healthcare facility. SMBG strips are widely used by diabetic patients to manage their condition effectively, helping them monitor fluctuations in blood glucose levels and make informed decisions regarding diet, medication, and lifestyle choices. The growing emphasis on early diagnosis and diabetes management is also contributing to market expansion, as both patients and healthcare providers seek convenient and accurate solutions for blood glucose monitoring. Furthermore, increasing awareness about preventive healthcare and the importance of continuous monitoring has fueled demand for SMBG strips in both developed and developing nations. Governments and healthcare organizations worldwide are actively promoting diabetes management programs, encouraging individuals to adopt self-monitoring practices to reduce complications and improve quality of life. The availability of reimbursement policies and initiatives aimed at making glucose testing affordable has further contributed to the market’s growth, making SMBG strips more accessible to patients across different economic backgrounds.
According to Publisher, the global Self-Monitoring Blood Glucose Strips market size was valued at US$ 23230 million in 2024. With growing demand in downstream market, the Self-Monitoring Blood Glucose Strips is forecast to a readjusted size of US$ 45240 million by 2030 with a CAGR of 10.0% during review period. The rapid advancements in glucose monitoring technologies have led to the development of more accurate, efficient, and easy-to-use blood glucose test strips. The introduction of innovative biosensors and enzyme-based test strips has enhanced the accuracy of glucose readings, reducing errors and ensuring more reliable data for patients and healthcare providers. Additionally, the integration of self-monitoring systems with digital platforms, such as mobile applications and cloud-based storage, has allowed for seamless tracking and analysis of glucose levels over time. This technological evolution has encouraged more individuals to adopt SMBG solutions, as they provide real-time insights into blood sugar trends and enable better disease management. Furthermore, the increasing focus on home-based healthcare and telemedicine has boosted demand for self-monitoring blood glucose strips, as individuals prefer non-invasive and cost-effective methods for disease management. The shift towards personalized medicine and patient-centric healthcare has further reinforced the importance of self-monitoring tools, as they empower individuals to take control of their health. While developed countries have witnessed higher adoption rates due to greater healthcare infrastructure and awareness, emerging economies are rapidly catching up, with improving access to diabetes care products and increasing penetration of healthcare technologies. The overall market landscape continues to evolve, driven by ongoing research and development efforts aimed at enhancing the efficiency, affordability, and user-friendliness of blood glucose test strips.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
The segmentation of the self-monitoring blood glucose strips market by type includes glucose oxidase, glucose dehydrogenase, and other enzyme-based test strips. Glucose oxidase-based strips are widely used due to their reliability and cost-effectiveness. These strips function by reacting with glucose in the blood sample, producing an electrochemical signal that determines blood sugar levels. Glucose oxidase-based strips have been popular in the market for years due to their stability and compatibility with many glucose meters. However, they have certain limitations, such as interference from oxygen levels in the blood, which can sometimes lead to inaccuracies in readings. On the other hand, glucose dehydrogenase-based strips offer higher accuracy and are less prone to oxygen interference. These strips utilize the glucose dehydrogenase enzyme, which provides more precise results and works effectively with a broader range of glucose meters. Due to their superior accuracy, glucose dehydrogenase-based strips are increasingly being preferred by both healthcare providers and individual users, especially those requiring frequent and precise monitoring. The category of other glucose test strips includes advanced biosensor-based technologies, which incorporate innovative materials and methodologies to enhance glucose monitoring accuracy. These emerging technologies are driving further improvements in self-monitoring capabilities, allowing for faster and more reliable blood glucose readings. As diabetes management evolves, the competition between different types of glucose strips continues, with advancements focusing on increasing ease of use, reducing blood sample requirements, and ensuring greater accuracy across various environmental conditions.
The segmentation of the self-monitoring blood glucose strips market by application highlights the major end-users, including hospitals, clinics, and households. Hospitals and healthcare facilities represent a significant portion of the market, as they require a large number of test strips for inpatient and outpatient diabetes monitoring. Healthcare professionals rely on SMBG strips for quick and efficient glucose testing in hospital settings, particularly for critically ill patients, surgical cases, and gestational diabetes monitoring. Clinics and diagnostic centers also contribute to substantial demand, as patients frequently visit these facilities for diabetes check-ups and glucose level assessments. These healthcare centers require high-quality, accurate test strips to ensure effective disease management and provide patients with real-time data to guide their treatment plans. However, the fastest-growing segment in the market is household usage, as more individuals adopt self-monitoring practices to manage their diabetes independently. The increasing preference for home-based care, driven by the need for convenience and cost savings, has resulted in a surge in demand for SMBG strips in household settings. Many patients, particularly those with type 1 and type 2 diabetes, use glucose strips multiple times a day, making household self-monitoring the largest and most dynamic segment in the market. The trend towards home-based healthcare has been further accelerated by the COVID-19 pandemic, which reinforced the importance of remote monitoring and minimizing hospital visits. The widespread adoption of telemedicine and digital health solutions has further strengthened the demand for SMBG strips, as patients seek seamless integration between glucose monitoring devices and mobile applications for real-time tracking. As self-monitoring continues to play a vital role in diabetes management, the market is expected to expand further, with innovations focusing on increasing user-friendliness, affordability, and accessibility across different healthcare settings.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information